Genentech Inc.’s income rose 237% to $15.2...

Genentech Inc.’s income rose 237% to $15.2 million in its first quarter, compared to $4.5 million for the year-ago period. The South San Francisco biotechnology company attributed its performance to a strong increase in the use of its growth hormone, Protropin, and its anti-blood clotting medication, Activase.